261 related articles for article (PubMed ID: 34159545)
1. Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.
Taylor JL; Johnson S; Cruz R; Gray JR; Schiff D; Bagley SM
J Gen Intern Med; 2021 Dec; 36(12):3810-3819. PubMed ID: 34159545
[TBL] [Abstract][Full Text] [Related]
2. Harm Reduction in Health Care Settings.
Chan CA; Canver B; McNeil R; Sue KL
Med Clin North Am; 2022 Jan; 106(1):201-217. PubMed ID: 34823731
[TBL] [Abstract][Full Text] [Related]
3. Addressing adolescent substance use with a public health prevention framework: the case for harm reduction.
Winer JM; Yule AM; Hadland SE; Bagley SM
Ann Med; 2022 Dec; 54(1):2123-2136. PubMed ID: 35900132
[TBL] [Abstract][Full Text] [Related]
4. Integrating substance use care into primary care for adolescents and young adults: Lessons learned.
Bagley SM; Hadland SE; Schoenberger SF; Gai MJ; Topp D; Hallett E; Ashe E; Samet JH; Walley AY
J Subst Abuse Treat; 2021 Oct; 129():108376. PubMed ID: 34080547
[TBL] [Abstract][Full Text] [Related]
5. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
[TBL] [Abstract][Full Text] [Related]
6. Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago.
Mason M; Post LA; Aggarwal R
BMC Health Serv Res; 2023 Aug; 23(1):876. PubMed ID: 37598163
[TBL] [Abstract][Full Text] [Related]
7. Commentary: The opioid overdose epidemic: Evidence-based interventions.
Barglow P
Am J Addict; 2018 Dec; 27(8):605-607. PubMed ID: 30311993
[TBL] [Abstract][Full Text] [Related]
8. Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder.
Osibanjo O; Reinhardt R; Clemans S; Andoniadis S; Carson P; Benkstein K
J Am Pharm Assoc (2003); 2023; 63(1):396-402. PubMed ID: 36564331
[TBL] [Abstract][Full Text] [Related]
9. Unintentional overdoses: understanding the fentanyl landscape and reducing harm.
Bell LA; Hadland SE
Curr Opin Pediatr; 2023 Aug; 35(4):408-414. PubMed ID: 36974444
[TBL] [Abstract][Full Text] [Related]
10. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
[TBL] [Abstract][Full Text] [Related]
11. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
[TBL] [Abstract][Full Text] [Related]
13. How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?
Salisbury-Afshar E; Livingston CJ; Bluthenthal RN
AMA J Ethics; 2024 Jul; 26(7):E562-571. PubMed ID: 38958425
[TBL] [Abstract][Full Text] [Related]
14. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
Arendt D
J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931
[TBL] [Abstract][Full Text] [Related]
15. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.
Krawczyk N; Fawole A; Yang J; Tofighi B
Addict Sci Clin Pract; 2021 Nov; 16(1):68. PubMed ID: 34774106
[TBL] [Abstract][Full Text] [Related]
16. Association between harm reduction strategies and healthcare utilization in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a protocol for a systematic review and meta-analysis.
Deschamps J; Gilbertson J; Straube S; Dong K; MacMaster FP; Korownyk C; Montgomery L; Mahaffey R; Downar J; Clarke H; Muscedere J; Rittenbach K; Featherstone R; Sebastianski M; Vandermeer B; Lynam D; Magnussen R; Bagshaw SM; Rewa OG
Syst Rev; 2019 Apr; 8(1):88. PubMed ID: 30953550
[TBL] [Abstract][Full Text] [Related]
17. A conceptual model for understanding post-release opioid-related overdose risk.
Joudrey PJ; Khan MR; Wang EA; Scheidell JD; Edelman EJ; McInnes DK; Fox AD
Addict Sci Clin Pract; 2019 Apr; 14(1):17. PubMed ID: 30982468
[TBL] [Abstract][Full Text] [Related]
18. Community Care in Reach: Mobilizing Harm Reduction and Addiction Treatment Services for Vulnerable Populations.
Regis C; Gaeta JM; Mackin S; Baggett TP; Quinlan J; Taveras EM
Front Public Health; 2020; 8():501. PubMed ID: 33102413
[TBL] [Abstract][Full Text] [Related]
19. Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.
Childs E; Biello KB; Valente PK; Salhaney P; Biancarelli DL; Olson J; Earlywine JJ; Marshall BDL; Bazzi AR
Int J Drug Policy; 2021 Apr; 90():103080. PubMed ID: 33340947
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
